The Ohio State University

Running trials

• Recruiting

  Symptoms of Polycystic Ovarian Syndrome Ameliorated by Keto-Adaptation Pilot

  NCT07227363· Source

• Not yet recruiting

  AAV2-hAADC for Parkinson's Disease (PDCS-01)

  NCT07267065· Phase 1· Source

• Recruiting

  Pacritinib Effectiveness in Real-world Settings

  NCT07774455· Source

• Recruiting

  Pridopidine Phase 3 Study in Huntington's Disease

  NCT07609108· Phase 3· Source

• Recruiting

  Determination of Resistance Training Status for Patients on Glucagon-Like Peptide-1 Receptor Agonists

  NCT07702461· Source

• Recruiting

  Randomized Controlled Trial of Two Mobile Health Strategies to Manage Postpartum Hypertension

  NCT07209254· Source

• Recruiting

  Zilucoplan for Severe gMG Exacerbations

  NCT07215949· Phase 3· Source

• Recruiting

  Study to Evaluate the Pharmacodynamics, Safety and Efficacy of SKY-0515 in Participants With Huntington's Disease

  NCT07378644· Phase 2/3· Source

• Recruiting

  Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care

  NCT07195591· Phase 3· Source

• Recruiting

  A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

  NCT07213674· Phase 3· Source

• Recruiting

  Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2

  NCT07225127· Source

• Recruiting

  A Study of SGT-212 Gene Therapy in Friedreich's Ataxia

  NCT07180355· Phase 1· Source

• Recruiting

  Motor-voice Assessment in Infants (MAMI)

  NCT06807203· Source

• Recruiting

  A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

  NCT07221500· Phase 2· Source

• Active, not recruiting

  Clinical Study of Neflamapimod in Patients With Primary Progressive Aphasia

  NCT07033481· Phase 2· Source

• Recruiting

  Anti-inflammatory Activities of Vitamin C Supplementation on the Gut Barrier Function in Adults With Obesity

  NCT07151105· Source

• Recruiting

  Implementing Scalable, PAtient-centered, Team-based, Technology-enabled Care for Adults With Type 2 Diabetes (iPATH)

  NCT06251323· Source

• Recruiting

  Water Competency Intervention in Autism

  NCT07076264· Source

• Recruiting

  Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma

  NCT06070012· Phase 2· Source

• Active, not recruiting

  A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease

  NCT07094516· Phase 2· Source

• Recruiting

  Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

  NCT06765109· Phase 3· Source

• Recruiting

  Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3

  NCT06891755· Source

• Recruiting

  Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

  NCT06699849· Phase 2· Source

• Recruiting

  Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina.

  NCT07048808· Phase 2· Source

• Recruiting

  The Multicenter Stress Cardiac Magnetic Resonance Quantitative Perfusion Imaging in the United States Study

  NCT06854458· Source

• Recruiting

  A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

  NCT06682793· Phase 1/2· Source

• Active, not recruiting

  An Early Feasibility Study Evaluation of an Implant Free Interatrial Shunt to Improve Heart Failure

  NCT06859970· Source

• Recruiting

  A Study of Ranolazine in ALS

  NCT06527222· Phase 2· Source

• Active, not recruiting

  T1D Pregnancy & Me

  NCT06959316· Source

• Recruiting

  A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies

  NCT06708897· Phase 1· Source

• Recruiting

  Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma

  NCT05077527· Phase 1· Source

• Recruiting

  A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC

  NCT06785636· Phase 1/2· Source

• Active, not recruiting

  A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy

  NCT06779773· Source

• Recruiting

  A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

  NCT06680830· Phase 2· Source

• Recruiting

  A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

  NCT06581406· Phase 2/3· Source

• Recruiting

  RESTORE: REducing Future fractureS and Improving ouTcOmes of fRagility fracturE

  NCT06455085· Source

• Recruiting

  Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors

  NCT06784193· Phase 1· Source

• Active, not recruiting

  Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute)

  NCT06691984· Phase 3· Source

• Recruiting

  Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer

  NCT06613100· Phase 1· Source

• Recruiting

  A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

  NCT06541704· Phase 3· Source

• Active, not recruiting

  A Clinical Trial to Learn About the Effects of VHB937 in People With Amyotrophic Lateral Sclerosis (ALS)

  NCT06643481· Phase 2· Source

• Recruiting

  Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)

  NCT06486454· Source

• Active, not recruiting

  A Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease

  NCT06388564· Phase 2· Source

• Recruiting

  DCE-MRI Guided Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer

  NCT06173310· Source

• Active, not recruiting

  Study of Emactuzumab for Tenosynovial Giant Cell Tumor (TGCT)

  NCT05417789· Phase 3· Source

• Recruiting

  Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

  NCT06561048· Phase 3· Source

• Recruiting

  Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)

  NCT06423430· Source

• Recruiting

  Study of BB-031 in Acute Ischemic Stroke Patients (RAISE)

  NCT06226805· Phase 2· Source

• Recruiting

  Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

  NCT06559306· Phase 3· Source

• Active, not recruiting

  DIAMOND-Lewy Guidelines for Antipsychotic Use in Older Patients

  NCT06357195· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Depression5 recruiting
• Prostate cancer5 recruiting
• Childhood cancers4 recruiting
• Lung cancer4 recruiting
• Myeloproliferative neoplasms4 recruiting
• Pancreatic cancer4 recruiting
• Chronic lymphocytic leukaemia3 recruiting
• Coronary artery disease3 recruiting
• Huntington's disease3 recruiting
• Melanoma3 recruiting
• Parkinson disease3 recruiting
• Acute myeloid leukemia2 recruiting
• Alzheimer disease2 recruiting
• Autism2 recruiting
• Bladder cancer2 recruiting
• Diffuse large B-cell lymphoma2 recruiting
• Head and neck cancer2 recruiting
• Heart failure2 recruiting
• HIV2 recruiting
• Myasthenia gravis2 recruiting
• Myelodysplastic syndromes2 recruiting
• Obesity2 recruiting
• Ovarian cancer2 recruiting
• Stroke2 recruiting
• Triple-negative breast cancer2 recruiting
• Acute lymphoblastic leukaemia1 recruiting
• ALS (motor neurone disease)1 recruiting
• ANCA-associated vasculitis1 recruiting
• Chronic myeloid leukaemia1 recruiting
• Colorectal cancer1 recruiting
• COPD1 recruiting
• Endometrial cancer1 recruiting
• Epilepsy1 recruiting
• Follicular lymphoma1 recruiting
• Friedreich ataxia1 recruiting
• Glioblastoma1 recruiting
• High blood pressure1 recruiting
• Idiopathic pulmonary fibrosis1 recruiting
• Kidney cancer1 recruiting
• Lewy body dementia1 recruiting
• Liver and biliary tract cancer1 recruiting
• Macular degeneration1 recruiting
• Metastatic breast cancer1 recruiting
• Multiple myeloma1 recruiting
• Osteoporosis1 recruiting
• Polycystic kidney disease1 recruiting
• Rheumatoid arthritis1 recruiting
• Sarcoma1 recruiting
• Sickle cell disease1 recruiting
• Type 1 diabetes1 recruiting
• Type 2 diabetes1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  A Study of ONO-2020 in Participants With Mild to Moderate Alzheimer's Disease

  NCT06881836· Phase 2· Source

• Completed

  Innovative Automated Insulin Delivery System for Type 2 Diabetes

  NCT06853990· Source

• Terminated

  BSB-1001 in Patients Undergoing HLA-Matched Allogenic Hematopoietic Stem Cell Transplant for AML, ALL or MDS

  NCT06704152· Phase 1/2· Source

• Completed

  A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)

  NCT06524830· Phase 2· Source

• Completed

  A Retrospective Chart Review Study of Patients With CLAD-BOS Post Lung Transplantation

  NCT06503770· Source

• Completed

  Feasibility and Acceptability of Incorporating Smartwatches Into an Exercise is Medicine Program in Older Individuals

  NCT06287255· Source

• Completed

  Effect of Moderate Renal Impairment and Race/Ethnicity on Treosulfan Pharmacokinetics

  NCT05534620· Phase 1· Source

• Recruiting

  BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT

  NCT06059638· Source

• Completed

  Inspiratory Muscle Training in Obese Breast Cancer Survivors

  NCT05193149· Source

• Terminated

  Open-Label Study of the CDK4/6 Inhibitor SPH4336 in Subjects With Locally Advanced or Metastatic Liposarcomas

  NCT05580588· Phase 2· Source

• Completed

  Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention

  NCT06055036· Source

• Completed

  Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC

  NCT05510908· Source

• Completed

  Respiratory Effects of E-Cigarettes in Obese Youth

  NCT05869318· Source

• Completed

  Re-Ablation Using a Tailored Approach Targeting EGM-Dispersion

  NCT05477147· Source

• Completed

  A Trial of the Safety and Efficacy of SEP-363856 in the Treatment of Adults With Major Depressive Disorder

  NCT05593029· Phase 2· Source

• Terminated

  Open-label Extension for Phase 3 Clinical Trials of Simufilam

  NCT05575076· Phase 3· Source

• Completed

  Study of the Safety and Neuroprotective Capacity of Scp776 in Acute Ischemic Stroke

  NCT05585606· Phase 2· Source

• Completed

  DORAYA-HF Early Feasibility Study

  NCT05206422· Source

• Completed

  A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder

  NCT04919512· Phase 2· Source

• Terminated

  Ultrafiltration Versus IV Diuretics in Worsening Heart Failure

  NCT05318105· Source

• Completed

  A Study of JNJ-55308942 in the Treatment of Bipolar Depression

  NCT05328297· Phase 2· Source

• Terminated

  Open-Label Extension of the PTI-125-04 Study in Mild-to-Moderate Alzheimer's Disease

  NCT05352763· Phase 2· Source

• Completed

  Activity Level Monitoring Study

  NCT05379088· Source

• Completed

  AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM

  NCT06378632· Source

• Terminated

  Study of Magrolimab Combinations in Patients With Relapsed/Refractory Multiple Myeloma

  NCT04892446· Phase 2· Source

• Completed

  Move to Improve: Telehealth Exercise to Music for HD

  NCT05270681· Source

• Completed

  Auditory Neural Function in Implanted Patients With Usher Syndrome

  NCT04906135· Source

• Completed

  Aquatic Therapy for ASD

  NCT05092321· Source

• Recruiting

  A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis

  NCT04951622· Phase 3· Source

• Completed

  A Study of AMG 757 in Participants With Neuroendocrine Prostate Cancer

  NCT04702737· Phase 1· Source

• Completed

  OUR Stress/ Emotion Management for Black/African American Women With Hypertension

  NCT04526145· Source

• Completed

  Cardionomic STOP-ADHF Study

  NCT04814134· Source

• Terminated

  CMP-001 in Combination With Nivolumab in Subjects With Advanced Melanoma

  NCT04698187· Phase 2· Source

• Completed

  An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD

  NCT04770545· Phase 3· Source

• Completed

  Learning and Improving Alzheimer's Patient-Caregiver Relationships Via Smart Healthcare Technology

  NCT04536701· Source

• Completed

  DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma

  NCT04334759· Phase 3· Source

• Completed

  Using Mental Imagination to Prevent Excessive Gestational Weight Gain in Overweight and Obese Pregnant Women

  NCT04623008· Source

• Completed

  Aqueous Humor Dynamic Components That Determine Intraocular Pressure Variance

  NCT04412096· Phase 4· Source

• Completed

  LUMINOS-101: Lerapolturev (PVSRIPO) and Pembrolizumab in Patients With Recurrent Glioblastoma

  NCT04479241· Phase 2· Source

• Completed

  Southeast Asian Women's Health Project

  NCT04086771· Source

• Terminated

  Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors

  NCT04383210· Phase 2· Source

• Completed

  Vardenafil Inhaled for Pulmonary Arterial Hypertension PRN Phase 2B Study

  NCT04266197· Phase 2· Source

• Completed

  A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant and Long-term Safety Extension Treatment With Seltorexant

  NCT04533529· Phase 3· Source

• Terminated

  Medtronic Deep Brain Stimulation (DBS) Therapy for Epilepsy Post-Approval Study (EPAS)

  NCT03900468· Source

• Terminated

  A Study of MT-0169 in Participants With Relapsed or Refractory Multiple Myeloma

  NCT04017130· Phase 1· Source

• Completed

  AB-1002 in Patients With Class III Heart Failure

  NCT04179643· Phase 1· Source

• Completed

  Trial of Parkinson's And Zoledronic Acid

  NCT03924414· Phase 4· Source

• Completed

  Study of DF1001 in Patients With Advanced Solid Tumors

  NCT04143711· Phase 1/2· Source

• Completed

  Persistent Postpartum Cardiovascular Dysfunction in Patients With Preeclampsia

  NCT04063397· Source

• Completed

  Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702)

  NCT03904134· Source